METTL3-driven m&lt;sup&gt;6&lt;/sup&gt;A modification of NLRC5 promotes renal fibrosis in chronic kidney disease through Keap1/Nrf2/ARE signaling pathway. Here, METTL3 is linked to renal fibrosis.